In vitro effects of glycyrrhetinic acid on the growth of clinical isolates of candida albicans

Phytotherapy Research

Volumn 23, Issue 4, 2009, Pages 572-574

  Pellati, Donatella ^a   Fiore, Cristina ^a   Armanini, Decio ^a   Rassu, Mario ^b   Bertoloni, Giulio ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c Microbiology and Medical Biotechnologies ^*  (Italy)

Author keywords

18 j8 glycyrrhetinic acid (18 j8 GA); Candida albicans; Glycyrrhiza glabra L.; Recurrent vulvovaginal candidiasis (RVVC)

Indexed keywords

18 BETA GLYCYRRHETINIC ACID; GLYCYRRHETINIC ACID; GLYCYRRHETINIC ACID DERIVATIVE; UNCLASSIFIED DRUG; 18ALPHA GLYCYRRHETINIC ACID; 18ALPHA-GLYCYRRHETINIC ACID; ANTIFUNGAL AGENT; DRUG DERIVATIVE; PLANT EXTRACT;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; DRUG MEGADOSE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; GLYCYRRHIZA; HUMAN; IN VITRO STUDY; LOW DRUG DOSE; MEDICINAL PLANT; NONHUMAN; PH; RECURRENT DISEASE; VAGINA CANDIDIASIS; CHEMISTRY; DRUG EFFECT; FEMALE; MICROBIOLOGY; PLANT ROOT;

CANDIDA ALBICANS; GLYCYRRHIZA; GLYCYRRHIZA GLABRA;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; FEMALE; GLYCYRRHETINIC ACID; GLYCYRRHIZA; HUMANS; PLANT EXTRACTS; PLANT ROOTS;

EID: 64549114177     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2693     Document Type: Article

References (15)

1. Armanini D, Karbowiak I, Funder JW. 1983. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol 19: 609-612.
2. Armanini D, Lewicka S, Pratesi C et al. 1996. Further studies on the mechanism of the mineralocorticoid action of licorice in humans. J Endocrinol Invest 19: 624-629.
3. Armanini D, Nacamulli D, Francini-Pesenti F, Battagin G, Ragazzi E, Fiore C. 2005. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids 70: 538-542.
4. Biswas S, Van Dijck P, Datta A. 2007. Environmental sensing and signal transduction pathways regulating morphopatho- genic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376.
5. Fidel PL Jr, Sobel JD. 1996. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 9: 335-348.
6. Fiore C, Eisenhut M, Krausse R et al. 2008. Antiviral effects of Glycyrrhiza species. Phytother Res 22: 141-148.
7. Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. 2005. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 99: 317-324.
8. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. 2002. Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus. Fitoterapia 73:536-539.
9. Kim HK, Park Y, Kim HN et al. 2002. Antimicrobial mechanism of β-glycyrrhetinic acid isolated from licorice, Glycyrrhiza glabra. Biotech Lett 24: 1899-1902.
10. Matsumoto T, Takahashi T, Yamada H. 2008. A novel approach for screening of new anti-Helicobacter pylori substances. Biol Pharm Bull 31: 143-145.
11. Motzei LM, Lindsey KL, van Staden J, Jager AK. 2003. Screening of traditionally used South African plants for antifungal activity against Candida albicans. J Ethnopharmacol 86: 235-241.
12. National Committee for Clinical Laboratory Standards. 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved standard, 2nd edn. NCCLS document M27-A2. 22 no 15. NCCLS: Wayne, PA.
13. Sobel JD. 1993. Candidal vulvovaginitis. Clin Obstet Gynecol 36: 153-212.
14. Sobel JD. 2003. Management of patients with recurrent vulvovaginal candidiasis. Drugs 63: 1059-1066.
15. Tsukiyama RI, Katsura H, Tokuriki N, Kobayashi M. 2002. Antibacterial activity of licochalcone A against spore-forming bacteria. Antimicrob Agents Chemother 46: 1226-1230.